Pharmacology

Article teaser image
Afatinib, a tyrosine kinase inhibitor, significantly improved progression-free survival compared to methotrexate in patients with recurrent or metastatic squamous cell carcinoma of the head and neck after failure of platinum-based chemotherapy, the results of a phase III trial presented at the ESMO 2014 Congress in Madrid show. The Lux-Head&Neck 1 trial showed that patients who received treatment with 40 mg/day oral afatinib had a 20% reduction in risk of progression or death compared to patients who received methotrexate, with a median progression-free survival of 2.6 months.…
Article teaser image
By:  Karin Heineman, Inside Science (Inside Science TV) – Dogs and cats can suffer from some of the same illnesses as humans such as allergies, cancer and even Alzheimer's disease. Currently pets are often given drugs designed for the human body that may not work the same way in the body of another species. For example, dogs with allergies are often prescribed the popular allergy drug Allegra. But, the formula was not designed for use by a dog and may not work correctly. Now, researchers at Kindred Biosciences in Burlingam, California are developing new drugs made just for pets. “We…
Article teaser image
Even a single dose of  the commonly prescribed antidepressant SSRI (serotonin reuptake inhibitor) is enough to produce dramatic changes in the functional architecture of the human brain. Brain scans taken of people before and after an acute dose of SSRI reveal changes in connectivity within three hours, according to results in Current Biology. While SSRIs are among the most widely studied and prescribed form of antidepressants worldwide, it's still not entirely clear how they work. The drugs are believed to change brain connectivity in important ways, but those effects had generally been…
Article teaser image
Between 2006 and 2011, high-dose opioid prescribing in Canada increased by 23 percent despite clinical guidelines recommending that most patients should avoid high-doses of these drugs, according to new research.  Researchers at St. Michael's Hospital and the Institute for Clinical Evaluative Sciences (ICES) found that rates of high-dose opioid dispensing across Canada increased from 781 units per 1,000 people in 2006 to 961 units per 1,000 people in 2011. "We found that high-dose prescribing was widespread across the country, but the prevalence differed considerably between provinces…
Article teaser image
We inherit certain traits that are predetermined but the field of epigenetics postulates that we might be able to change genes play by taking certain drugs or changing diets.   Epigenetics regulates gene expression in a reversible manner by chemically modifying DNA and histone proteins, which prevent permanent mutations or alterations within the gene themselves. Throughout DNA processing, a single strand will go through countless modifications that determine whether certain genes will eventually be expressed. A single addition or subtraction of a few carbon and hydrogen ions can…
Article teaser image
Recently a study was published in the Milbank Quarterly analyzing the voting patterns of FDA Advisory Committee members with apparent conflicts of interest. Since I would have to pay to actually get access to the full article, in my retired state I relied on the abstract and on a very useful New York Times article by Aaron Carroll for my blog today.  The author, Genevieve Pham-Kanter, analyzed the voting patterns of almost 400 FDA advisory committee members between 1997 and 2011. This involved almost 16,000 votes in almost 400 different advisory committee meetings. Some 13% of…
Article teaser image
A protein called Nrf2,continually moves in and out of the nuclei of human cells to sense the cell's health and vitality and when Nrf2 is exposed to threats to the cell's health, it oscillates faster and activates an increase in the cell's defense mechanism, including raising the levels of antioxidants. A recent study successfully increased the speed of Nrf2's movement by artificially introducing health beneficial substances – potential components of new superfoods, meaning a new new generation of compounds that could help tackle heart disease and diabetes.  The beneficial substances…
Article teaser image
Generic drugs and biosimilar drugs are conceptually equivalent, though a biosimilar drug is not a generic drug. Generics drugs are equivalent copycats - exact copies of molecules that were developed at great cost by companies that are now outside the patent window. Biosimilars are instead copies of molecules of a protein nature involving biological processes and materials, like cell culture or the extraction of products using living organisms, which is why there is no product that is exactly the same as the other. Basically, that is why the name 'biosimilar' exists, because unlike generics…
Article teaser image
Treatment with xenon gas reduces the extent of brain damage after a head injury reduces the extent of brain damage, according to a new study. Head injury is the leading cause of death and disability in people under 45 in developed countries - due primarily to falls and road accidents. The primary injury caused by the initial mechanical force is followed by a secondary injury which develops in the hours and days afterwards. This secondary injury is largely responsible for patients' mental and physical disabilities, but there are currently no drug treatments that can be given after the accident…
Article teaser image
A team of researchers have evaluated mepolizumab, a new antibody-based drug for certain patients with severe asthma, and found it can replace traditional, steroid-based treatments for a specific subset of patients, resulting in improved outcomes and reduced side effects. Patients with severe asthma often require high doses of steroid-based treatments that can significantly impair their quality of life. These high doses can cause debilitating side effects including mood swings, diabetes, bone loss, skin bruising, cataracts and hypertension. Previous research at the Hamilton institutions has…